Cervical cancer, driven by high-risk human papillomavirus (HR-HPV), remains a leading cause of cancer-related death. Annually, 600,000 women are diagnosed, and nearly 300,000 die from the disease. Current treatments utilize surgery and chemoradiation, which are not selective for HPV-infected cells and are less effective in advanced disease stages. These limitations highlight the need for therapies...
See More →
